Burri C. Sleeping sickness at the crossroads. Trop Med Infect Dis. 2020;5(2):57. DOI: 10.3390/tropicalmed5020057

2020
Journal Item
PubMed (32276514)
Link

De Pretto-Lazarova A, Brancati-Badarau D.O, Burri C. Informed consent approaches for clinical trial participation of infants with minor parents in sub-Saharan Africa: a systematic review. PLoS One. 2020;15(8):e0237088. DOI: 10.1371/journal.pone.0237088

2020
Journal Article
PubMed (32750084)
Link

Dickie E.A, Giordani F, Gould M.K, Mäser P, Burri C, Mottram J.C, Rao S.P.S, Barrett M.P. New drugs for human african trypanosomiasis: a twenty first century success story. Trop Med Infect Dis. 2020;5:29. DOI: 10.3390/tropicalmed5010029

2020
Journal Article
PubMed (32092897)
Link

Mudji J, Blum A, Grize L, Wampfler R, Ruf M.T, Cnops L, Nickel B, Burri C, Blum J. Gambiense human african trypanosomiasis sequelae after treatment: a follow-up study 12 years after treatment. Trop Med Infect Dis. 2020;5(1):10. DOI: 10.3390/tropicalmed5010010

2020
Journal Article
PubMed (31940846)
Link

Seixas J, Atouguia J, Josenando T, Vatunga G, Bilenge C.M.M, Lutumba P, Burri C. Clinical study on the melarsoprol-related encephalopathic syndrome: risk factors and HLA association. Trop Med Infect Dis. 2020;5(1):5. DOI: 10.3390/tropicalmed5010005

2020
Journal Article
PubMed (31906333)
Link

Mudji J, Benhamou J, Mwamba-Miaka E, Burri C, Blum J. The flipside of eradicating a disease; human African trypanosomiasis in a woman in rural Democratic Republic of Congo: a case report. Trop Med Infect Dis. 2019;4(4):142. DOI: 10.3390/tropicalmed4040142

2019
Journal Article
PubMed (31835660)
Link

Nzolo D, Kümmerle A, Lula Y, Ntamabyaliro N, Engo A, Mvete B, Liwono J, Lusakibanza M, Mesia G, Burri C, Mampunza S, Tona G. Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo. Ther Adv Drug Saf. 2019;10:2042098619864853. DOI: 10.1177/2042098619864853

2019
Journal Article
PubMed (31360433)
Link

Kümmerle A, Akakpo S, Liwono J, Duparc S, Burri C, Stergachis A. Drug utilization and drug-drug interaction studies in the field: examples of South-North collaboration projects. Drug Safety, 2018;41(11):1120-1121

2018
Conference Paper

Ntamabyaliro N.Y, Burri C, Nzolo D.B, Engo A.B, Lula Y.N, Mampunza S.M, Nsibu C.N, Mesia G.K, Kayembe J.N, Likwela J.L, Kintaudi L.M, Tona G.L. Drug use in the management of uncomplicated malaria in public health facilities in the Democratic Republic of the Congo. Malar J. 2018;17:189. DOI: 10.1186/s12936-018-2332-3

2018
Journal Article
PubMed (29724210)
Link

Simon A, Marzolini C, Vanobbergen F, Burri C, Kümmerle A. Reporting of qt interval prolongation and torsade de pointe for HIV-antiretrovirals in vigibase: focus on potential drug-drug interactions. Drug Safety, 2018;41(11):1178-1179

2018
Conference Paper

Burri C, Blum J. Human African trypanosomiasis. In: Cohen Jonathan,Powderly William G,Opal Steven M, eds. Infectious Diseases. 2, 966-970;1761-1762: Elsevier, 2017

2017
Book Section

Kümmerle A, Mäder M, Sartori D, Lazarova A, Urich M, Dodoo A, Olsson S, Burri C. Contribution of adverse events reporting of HIV antiretrovirals to VigiBase: Comparison between sub-Saharan Africa and the rest of the world. Drug Safety. 2017;40(10):987-988

2017
Journal Item

Kümmerle A, Sartori D, Maeder M, Lazarova A, Urich M, Dodoo A, Olsson S, Burri C. Spontaneous reporting characteristics of HIV antiretrovirals in vigibase: disproportionate analysis between sub-Saharan Africa and the rest of the world. Drug Saf, 2017;40(10):988-989

2017
Conference Paper

Vischer N, Pfeiffer C, Kealy J, Burri C. Increasing protocol suitability for clinical trials in sub-Saharan Africa: a mixed methods study. Glob Health Res Policy. 2017;2:11. DOI: 10.1186/s41256-017-0031-1

2017
Journal Article
Link

Vischer N, Pfeiffer C, Limacher M, Burri C. "You can save time if..."-a qualitative study on internal factors slowing down clinical trials in sub-Saharan Africa. PLoS One. 2017;12(3):e0173796. DOI: 10.1371/journal.pone.0173796

2017
Journal Article
PubMed (28301530)
Link

Burri C, Yeramian P.D, Allen J.L, Merolle A, Serge K.K, Mpanya A, Lutumba P, Mesu V.K, Bilenge C.M, Lubaki J.P, Mpoto A.M, Thompson M, Munungu B.F, Manuel F, Josenando T, Bernhard S.C, Olson C.A, Blum J, Tidwell R.R, Pohlig G. Efficacy, safety, and dose of pafuramidine, a new oral drug for treatment of first stage sleeping sickness, in a phase 2a clinical study and phase 2b randomized clinical studies. PLoS Negl Trop Dis. 2016;10(2):e0004362. DOI: 10.1371/journal.pntd.0004362

2016
Journal Article
PubMed (26881924)
Link

Ntuku H.M, Ferrari G, Burri C, Tshefu A.K, Kalemwa D.M, Lengeler C. Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo. Malar J. 2016;15:18. DOI: 10.1186/s12936-015-1072-x

2016
Journal Article
PubMed (26747281)
Link

Pohlig G, Bernhard S.C, Blum J, Burri C, Mpanya A, Lubaki J.P, Mpoto A.M, Munungu B.F, N'tombe P.M, Deo G.K, Mutantu P.N, Kuikumbi F.M, Mintwo A.F, Munungi A.K, Dala A, Macharia S, Bilenge C.M, Mesu V.K, Franco J.R, Dituvanga N.D, Tidwell R.R, Olson C.A. Efficacy and safety of pafuramidine versus pentamidine maleate for treatment of first stage sleeping sickness in a randomized, comparator-controlled, international phase 3 clinical trial. PLoS Negl Trop Dis. 2016;10(2):e0004363. DOI: 10.1371/journal.pntd.0004363

2016
Journal Article
PubMed (26882015)
Link

Vischer N, Pfeiffer C, Joller A, Klingmann I, Ka A, Kpormegbe S.K, Burri C. The good clinical practice guideline and its interpretation - perceptions of clinical trial teams in sub-Saharan Africa. Trop Med Int Health. 2016;21(8):1040-1048. DOI: 10.1111/tmi.12734

2016
Journal Article
PubMed (27260671)

Ferrari G, Ntuku H.M, Burri C, Kitoto A.T, Duparc S, Hugo P, Mitembo D.K, Ross A, Ngwala P.L, Luwawu J.N, Musafiri P.N, Ngoie S.E, Lengeler C. An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study. Malar J. 2015;14:226. DOI: 10.1186/s12936-015-0732-1

2015
Journal Article
PubMed (26024661)
Link

Ferrari G, Ntuku H.M, Burri C, Kitoto A.T, Duparc S, Hugo P, Mitembo D.K, Ross A, Ngwala P.L, Luwawu N, Musafiri P.N, Ngoie S.E, Lengeler C. An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in The Democratic Republic of Congo: the MATIAS study. Trop Med Int Health, 2015;20(Suppl. 1):91. Abstracts of the 9th European Congress on Tropical Medicine and International Health, 6-10 September 2015, Basel, Switzerland

2015
Conference Paper

Gajewski S, Burri C. Clinical research data management: solutions for low-resource settings. Trop Med Int Health, 2015;20(Suppl. 1):432-433

2015
Conference Paper

Signorell A, Torrente M, Scherrer B, Mordt O.V, Strub-Wourgaft N, Tarral A, Burri C. Safety and efficacy of fexinidazole against rhodesiense human African trypanosomiasis: approach to conducting a clinical trial for a very rare, neglected disease. Trop Med Int Health, 2015;20(Suppl. 1):337. Abstracts of the 9th European Congress on Tropical Medicine and International Health, 6-10 September 2015, Basel, Switzerland

2015
Conference Paper

Vischer N, Pfeiffer C, Burri C. Improving efficiency and quality in clinical trials in sub-Saharan Africa. Trop Med Int Health, 2015;20(Suppl. 1):125. Abstracts of the 9th European Congress on Tropical Medicine and International Health, 6-10 September 2015, Basel, Switzerland

2015
Conference Paper

Burri C, Chappuis F, Brun R. Human African trypanosomiasis. In: Farrar J,Hotez P.J,Junghanss T,Kang G,Lalloo D,White N.J, eds. Manson's Tropical Diseases, 606-621. [Edinburgh]: Saunders, 2014

2014
Book Section

Burri C, Ferrari G, Ntuku H.M, Kitoto A.T, Duparc S, Hugo P, Mitembo D.K, Lengeler C. Delayed anemia after treatment with injectable artesunate in the democratic republic of the Congo: a manageable issue. Am J Trop Med Hyg. 2014;91(4):821-823. DOI: 10.4269/ajtmh.14-0149

2014
Journal Article
PubMed (25071004)

Burri C. Antiprotozoals for human African trypanosomiasis: the heart of darkness at dawn [Commentary]. Clin Invest. 2014;4(1):13-18. DOI: 10.4155/CLI.13.116

2014
Journal Item

Williams J.R, Sprumont D, Hirtle M, Adebamowo C, Braunschweiger P, Bull S, Burri C, Czarkowski M, Fan C.T, Franck C, Gefenas E, Geissbuhler A, Klingmann I, Kouyate B, Kraehenbhul J.P, Kruger M, Moodley K, Ntoumi F, Nyirenda T, Pym A, Silverman H, Tenorio S. Consensus standards for introductory e-learning courses in human participants research ethics. J Med Ethics. 2014;40(6):426-428. DOI: 10.1136/medethics-2013-101572

2014
Journal Article
PubMed (23959838)

Burri C, Ferrari G, Ntuku H.M, Mitembo D.K, Ngwala P.L, Luwawu J.J.N, Musafiri P.N, Ngoie S.E, Hugo P, Kitoto A.T, Lengeler C. Treatment of severe malaria: an operational comparison between quinine and artesunate for the treatment of severe malaria in seven health facilities in the democratic republic of the Congo - "Matias". Am J Trop Med Hyg, 2013;89(5 Suppl.):199

2013
Conference Paper

Burri C. An alternative form of melarsoprol in sleeping sickness: is an old drug always the best basis for a new one? [Letter]. Trends Parasitol. 2012;28(9):354-355. DOI: 10.1016/j.pt.2012.06.002

2012
Journal Item
PubMed (22867944)

Küpfer I, Schmid C, Allan M, Edielu A, Haary E.P, Kakembo A, Kibona S, Blum J, Burri C. Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage rhodesiense sleeping sickness. PLoS Negl Trop Dis. 2012;6(8):e1695. DOI: 10.1371/journal.pntd.0001695

2012
Journal Article
PubMed (22970329)
Link

Kümmerle A, Dodoo A.N.O, Olsson S, Van Erps J, Burri C, Lalvani P.S. Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring. Malar J. 2011;10:57. DOI: 10.1186/1475-2875-10-57

2011
Journal Article
PubMed (21388536)
Link

Küpfer I, Hhary E.P, Allan M, Edielu A, Burri C, Blum J.A. Clinical presentation of T.b. rhodesiense sleeping sickness in second stage patients from Tanzania and Uganda. PLoS Negl Trop Dis. 2011;5(3):e968. DOI: 10.1371/journal.pntd.0000968

2011
Journal Article
PubMed (21407802)
Link

Probst-Hensch N, Tanner M, Kessler C, Burri C, Kunzli N. Prevention--a cost-effective way to fight the non-communicable disease epidemic: an academic perspective of the United Nations High-level NCD Meeting. Swiss Med Wkly. 2011;141:w13266. DOI: 10.4414/smw.2011.13266

2011
Journal Article
PubMed (21901650)
Link

Schweizerisches Tropen- und Public Health-Institut. Eine vergessene Seuche: Erforschung und Bekämpfung der afrikanischen Schlafkrankheit am Swiss TPH. Basel: Schweizerisches Tropen- und Public Health-Institut, 2011

2011
Book
Link

Swiss Tropical and Public Health Institute. A forgotten epidemic: study and prevention of African sleeping sickness at the Swiss TPH. Basel: Swiss Tropical and Public Health Institute, 2011

2011
Book
Link

Brun R, Blum J, Chappuis F, Burri C. Human African trypanosomiasis. Lancet. 2010;375(9709):148-159. DOI: 10.1016/S0140-6736(09)60829-1

2010
Journal Article
PubMed (19833383)

Burri C. Chemotherapy against human African trypanosomiasis: is there a road to success?. Parasitology. 2010;137(14):1987-1994. DOI: 10.1017/S0031182010001137

2010
Journal Article
PubMed (20961469)

Matovu E, Küpfer I, Boobo A, Kibona S, Burri C. Comparative detection of trypanosomal DNA by loop mediated isotherma amplification and PCR from FTA cards spotted with patient blood. J Clin Microbiol. 2010;48(6):2087-2090. DOI: 10.1128/JCM.00101-10

2010
Journal Article
PubMed (20410347)

Paine M.F, Wang M.Z, Generaux C.N, Boykin D.W, Wilson W.D, de Koning H.P, Olson C.A, Pohlig G, Burri C, Brun R, Murilla G.A, Thuita J.K, Barrett M.P, Tidwell R.R. Diamidines for human African trypanosomiasis. Curr Opin Investig Drugs. 2010;11(8):876-883

2010
Journal Article
PubMed (20721830)